NODES_INNDIANA_Z99_Very Low Energy Ketogenic Therapy improves MASLD and Metabolic Dysfunction in patients with Type 2 Diabetes and Obesity
Individuals with coexistence of metabolic disorders, including type 2 diabetes, obesity, and MASLD were administered for 12 weekd with a VLEKT protocol. After 12 weeks with the intervention patients imrpoved their metabolic, lipidic and hepatic profile significanlty. During the study, individuals underwent anthropometric, clinical and food questionnaires evaluation. Patients are followed within specific time point by qualified personnel.
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-08-14
- DOI
- https://doi.org/10.5281/zenodo.16877114
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00